Second, Li et al. 55and Soares et al. 44showed that anti-PD-1/PD-L1 antibodies enhanced antitumor activities of the GM-CSF-secreting cancer vaccine (GVAX) in both mouse models of colon cancer and pancreatic cancer, respectively. This evidence concerns the gene CSF2 and familial pancreatic carcinoma.